MANNKIND CORP Stock Issued During Period, Shares, Employee Stock Purchase Plans
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- MANNKIND CORP stock issued during period, shares, employee stock purchase plans for fiscal 2017 was 199.58K shares, a 90.51% increase from fiscal 2016.
- MANNKIND CORP stock issued during period, shares, employee stock purchase plans for fiscal 2016 was 104.76K shares, a 63.06% increase from fiscal 2015.
- MANNKIND CORP stock issued during period, shares, employee stock purchase plans for fiscal 2015 was 64.25K shares, a 5.29% increase from fiscal 2014.
- MANNKIND CORP stock issued during period, shares, employee stock purchase plans for fiscal 2014 was 61.02K shares, a 86.83% decline from fiscal 2013.
| Period end | Stock Issued During Period, Shares, Employee Stock Purchase Plans 3 month | Stock Issued During Period, Shares, Employee Stock Purchase Plans 12 month |
|---|---|---|
| 2017-12-31 | 199.58K shares 10-K · filed 2018-02-27 | |
| 2016-12-31 | 104.76K shares 10-K · filed 2018-02-27 | |
| 2015-12-31 | 64.25K shares 10-K · filed 2018-02-27 | |
| 2014-12-31 | 61.02K shares 10-K · filed 2017-03-16 | |
| 2013-12-31 | 463.29K shares 10-K · filed 2016-03-15 | |
| 2012-12-31 | 422.26K shares 10-K · filed 2015-03-02 | |
| 2011-12-31 | 282.82K shares 10-K · filed 2014-03-03 | |
| 2010-12-31 | 287.60K shares 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |